Years Active: 2025
Title: Cecillia Cotta-Ramusino: Innovator in Genome Editing for Hyper IgM Syndrome
Introduction
Cecillia Cotta-Ramusino is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of genome editing, particularly in the treatment of Hyper IgM Syndrome. Her innovative work has the potential to transform the lives of individuals affected by this disorder.
Latest Patents
Cotta-Ramusino holds a patent for "Systems and methods for treating hyper-igm syndrome." This patent discloses genome editing systems and related methods that allow for the treatment of Hyper IgM Syndrome, a group of disorders characterized by defective CD40 signaling. The compositions and methods described in her patent rely on the use of donor templates comprising CD40L exons to restore proper CD40 signaling and B cell class switch recombination. She has 1 patent to her name.
Career Highlights
Throughout her career, Cecillia has worked with notable organizations, including Editas Medicine, Inc. and Fondazione Telethon Ets. Her experience in these companies has allowed her to collaborate with leading experts in the field of genetic research and therapy.
Collaborations
Cotta-Ramusino has collaborated with esteemed colleagues such as Carrie M. Margulies and Luigi Naldini. These partnerships have further enhanced her research and development efforts in genome editing technologies.
Conclusion
Cecillia Cotta-Ramusino is a trailblazer in the field of genome editing, with her work on Hyper IgM Syndrome showcasing her innovative spirit and dedication to improving healthcare outcomes. Her contributions are paving the way for future advancements in genetic therapies.